Melatonin Benefits: Evidence-Backed Effects
Melatonin is a hormone produced by the pineal gland in response to darkness, and it is the most widely sold sleep supplement in the world. It signals to the body that it is time to sleep. As a supplement, melatonin is taken to help with sleep onset, jet lag, and shift-work sleep disruption. This guide reviews what the research actually supports — and where claims outrun the evidence.
Primary Evidenced Benefits
Sleep Onset (Circadian Phase Shifting)
The strongest evidence for melatonin is its role in shifting the timing of the body's internal clock. A meta-analysis by Ferracioli-Oda et al. (2013) covering 19 randomised trials found that melatonin supplementation significantly reduced the time to fall asleep and improved sleep quality compared with placebo. The effect was statistically significant and consistent across study populations.
This effect is most pronounced when the problem is a delayed circadian phase — for example, difficulty falling asleep before midnight. Melatonin is less effective for middle-of-the-night waking or early morning awakening, which have different underlying mechanisms.
Jet Lag
Jet lag is one of the most evidence-supported uses for melatonin. A Cochrane review (Herxheimer & Petrie, 2002) assessed 10 randomised trials and concluded that melatonin is remarkably effective in preventing or reducing jet lag. Effect is most reliable for eastward travel (where phase advance is needed) and for crossings of five or more time zones.
The reviewed dosing range was approximately 0.5–5 mg taken close to the target bedtime in the new time zone.
Secondary and Emerging Effects
- Shift-work sleep disorder: Evidence supports melatonin for improving daytime sleep quality in night-shift workers, though effect sizes are modest.
- Sleep quality in older adults: Melatonin production declines with age. Some trials in older adults show improvements in sleep initiation and quality at low doses (0.5–2 mg), though a 2021 Cochrane review found inconsistent results across trials.
- Antioxidant properties: Melatonin has well-documented antioxidant activity in cell studies. Whether this translates to clinically meaningful protection in humans at supplemental doses is less clear — the evidence is mechanistically interesting but not yet sufficient for clinical claims.
Where Evidence Is Weak
- General insomnia in healthy young adults without circadian misalignment: Effect sizes are typically small, and melatonin does not address the underlying causes of non-circadian insomnia (anxiety, poor sleep hygiene, etc.).
- Athletic recovery and muscle repair: Some trials explore melatonin's antioxidant role post-exercise, but evidence is too preliminary to support supplementation for this purpose.
- Mood and anxiety: Mechanistic plausibility exists, but controlled trial evidence is insufficient and inconsistent.
Who Gains Most
Melatonin is most likely to benefit:
- People with delayed sleep phase disorder (strong evidence)
- Frequent travellers crossing multiple time zones (strong evidence)
- Night-shift workers trying to improve daytime sleep quality (moderate evidence)
- Older adults with age-related decline in endogenous melatonin (moderate evidence)
- People experiencing temporary sleep disruption from irregular schedules
For otherwise healthy adults with a stable sleep schedule and no circadian disruption, exogenous melatonin adds little.
Realistic Expectations
Melatonin is not a sedative in the conventional sense — it does not knock you out. It shifts the timing of sleepiness rather than forcing sleep. At typical supplemental doses of 0.5–3 mg, most people experience a gentle increase in sleepiness and some improvement in sleep onset. Higher doses (5–10 mg) do not consistently outperform lower doses and increase the risk of next-morning grogginess.
Melatonin is considered safe for short-term use. The EFSA health claim that 0.5 mg of melatonin consumed close to bedtime contributes to the reduction of sleep onset latency has been authorised — this is one of the few substantiated sleep claims in EU supplement regulation (EFSA, 2011).
Browse melatonin products at maxfit.ee/et/category/melatoniin.
FAQ
What dose of melatonin should I take?
For sleep onset, doses as low as 0.5 mg are effective — this is the dose for which EFSA has authorised a health claim. Doses up to 3 mg are commonly used and well tolerated. There is no evidence that doses above 5 mg provide additional benefit for most uses; they are more likely to cause morning grogginess.
Is melatonin safe to take every night?
Melatonin is considered safe for short-term nightly use (weeks to a few months). Long-term daily use has not been studied in large controlled trials. If you need melatonin every night for more than 3 months, it is worth discussing with a healthcare provider to investigate underlying causes of sleep difficulties.
Can melatonin help with jet lag?
Yes — this is the best-supported use for melatonin. Take 0.5–3 mg close to your target bedtime in the new time zone. The effect is most reliable for eastward travel across five or more time zones.
References
Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773. https://doi.org/10.1371/journal.pone.0063773
Herxheimer, A., & Petrie, K. J. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, 2002(2), CD001520. https://doi.org/10.1002/14651858.CD001520
EFSA Panel on Dietetic Products, Nutrition and Allergies. (2011). Scientific Opinion on the substantiation of health claims related to melatonin. EFSA Journal, 9(6), 2241. https://doi.org/10.2903/j.efsa.2011.2241
